① is more accurate than ChatGPT! The company has created a large model product with 6 billion parameters of "AI+ Healthcare", which is expected to play value in the whole clinical process in the future. The company's overall financial data at a low base may be significantly improved after the second quarter, and analysts think profits may increase by 288% this year. The compound profit growth rate of ② in the next three years may reach 84%, and the long-term PE is less than 10 times. The company's energy storage business is about to enter the harvest period, and the number of channels in the high potential market in Latin America has doubled, with a market share of 20%. At present, the company's share price has fallen nearly 60% from the high point, with the characteristics of "low stock price + low valuation + performance support".